CD274 and neoplasm: A murine myeloma model using 5T33 cell lines showed that a whole-tumor cell vaccine combined with the anti-PD-L1 antibody increased the antimyeloma effects compared with tumor-cell vaccination alone or the anti-PD-L1 antibody alone [42].